Nov 14, 2022 6:47am EST NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Nov 14, 2022 1:15am EST Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Nov 10, 2022 6:47am EST NRx Pharmaceuticals to Report Third Quarter 2022 Results on November 14, 2022
Nov 09, 2022 6:47am EST NRx Pharmaceuticals Produces First Phase 3-stage NRX-101 Drug Made Using Commercial Process
Sep 08, 2022 6:40am EDT NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference
Aug 22, 2022 6:00am EDT RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION
Aug 15, 2022 6:50am EDT NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advancement of its Psychiatry Franchise
